Henderson Molly (CIK 0001363812)

Latest company ownership

Shares held
30,000
Last filed at
Feb 2, 2022
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q2 2025Q4
Shares held
1,911.27
Last filed at
May 31, 2024
Confidence Score
49.8
2025Q4
Confidence Score History
2022Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 7, 2025 Apr 8, 2025 Phathom Pharmaceuticals, Inc. CFO Sell 46.3 -3,678 -3.85% ✗ $16.7K
Jan 21, 2025 Jan 23, 2025 Phathom Pharmaceuticals, Inc. CFO Sell 46.3 -6,583 -6.45% ✗ $43.4K
Dec 19, 2024 Dec 20, 2024 Phathom Pharmaceuticals, Inc. CFO Sell 46.3 -1,291 -1.27% ✗ $10.3K
Jul 15, 2024 Jul 17, 2024 Phathom Pharmaceuticals, Inc. CFO Sell 42.5 -4,325 -4.09% ✗ $50.7K
Apr 8, 2024 Apr 10, 2024 Phathom Pharmaceuticals, Inc. CFO Sell 46.3 -3,435 -3.41% ✗ $38.1K
Jan 19, 2024 Jan 22, 2024 Phathom Pharmaceuticals, Inc. CFO Sell 46.3 -6,307 -5.90% ✗ $48.9K
Nov 20, 2023 Nov 21, 2023 Phathom Pharmaceuticals, Inc. CFO Sell 46.3 -2,127 -2.00% ✗ $15.4K
Nov 1, 2023 Nov 3, 2023 Phathom Pharmaceuticals, Inc. CFO Sell 95.0 +10,008 10.39% ✗ $110.9K
Jun 2, 2023 Jun 5, 2023 Phathom Pharmaceuticals, Inc. CFO Sell 45.0 -1,960 -2.77% ✓ $22.4K
May 22, 2023 May 23, 2023 Phathom Pharmaceuticals, Inc. CFO Sell 45.0 -2,110 -2.89% ✓ $27.2K
Apr 6, 2023 Apr 7, 2023 Phathom Pharmaceuticals, Inc. CFO Sell 41.3 -3,439 -4.50% ✓ $25K
Mar 1, 2023 Mar 3, 2023 Phathom Pharmaceuticals, Inc. CFO Sell 45.0 -2,032 -2.59% ✓ $17.3K
Nov 21, 2022 Nov 23, 2022 Phathom Pharmaceuticals, Inc. CFO Sell 46.3 -2,159 -4.71% ✗ $20.7K
Jan 31, 2022 Feb 2, 2022 UroGen Pharma Ltd. CFO Sell 47.5 -331 -5.93% ✗ $2.5K
Nov 30, 2021 Dec 2, 2021 UroGen Pharma Ltd. CFO Sell 46.3 -2,587 -34.49% ✗ $31.1K
May 17, 2021 May 18, 2021 UroGen Pharma Ltd. CFO Buy 91.3 +2,500 100.00% ✗ $39.6K